TY - JOUR
T1 - Add-on inhaled budesonide in the treatment of hospitalised patients with COVID-19: a randomised clinical trial.
AU - Agustí, Alvar
AU - De Stefano, Gaston
AU - Levi, Alberto
AU - Muñoz, Xavier
AU - Romero-Mesones, C
AU - Sibila, Oriol
AU - Lopez-Giraldo, Alejandra
AU - Moral, VP
AU - Curto, Elena
AU - Echazarreta, Andrés L.
AU - Márquez, Silvana E
AU - Pascual-Guardia, Sergi
AU - Santos, Salud
AU - Marin, Alicia
AU - Valdés, Luis
AU - Saldarini, Fernando
AU - Salgado, Clara
AU - Casanovas, Georgina
AU - Varea, Sara
AU - Ríos, José
AU - Faner, R
PY - 2022/2
Y1 - 2022/2
N2 - The addition of inhaled budesonide to usual care is safe and may reduce the risk of disease progression in patients hospitalised because of COVID-19 pneumonia
AB - The addition of inhaled budesonide to usual care is safe and may reduce the risk of disease progression in patients hospitalised because of COVID-19 pneumonia
UR - http://europepmc.org/abstract/med/35144989
U2 - 10.1183/13993003.03036-2021
DO - 10.1183/13993003.03036-2021
M3 - Article
C2 - 35144989
VL - 59
JO - The European respiratory journal
JF - The European respiratory journal
IS - 3
ER -